Clinical Trial Update: A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants [Phase 2]

View source ↗

Summary

A Phase 2 study of IC265 Ophthalmic Solution for dry eye in adults was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• IC265 Ophthalmic Solution

Snippet

Sponsor: Iacta Pharmaceuticals | Conditions: Dry Eye Syndromes | Phase 2 | Status: TERMINATED | Results posted: 2025-04-25